OTHER · Unmapped registry intervention
Upstream therapy
Find medicine records ·
Find other trials using this name
Clinical trial
Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure
NCT00877643
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Conventional rhythm control
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRoutine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
I.C. Van Gelderlead sponsor
Netherlands Heart Foundationcollaborator
Dutch Network for Cardiovascular Researchcollaborator
Trial Coordination Center UMC Groningencollaborator
Bayercollaborator
Boehringer Ingelheimcollaborator
Medtroniccollaborator
Biotronik SE & Co. KGcollaborator
Abbott Medical Devicescollaborator
Boston Scientific Corporationcollaborator
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00877643 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.